YOUR BUSINESS AUTHORITY
Springfield, MO
Novo Nordisk announced plans for a new acquisition.
The Danish pharmaceutical company agreed to buy Germany-based Cardior Pharmaceuticals for $1.1 billion.
Cardior makes therapies that target RNA to prevent and treat heart diseases, according to Quartz.
Read more from Quartz.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
SBJ announces executive newsroom hires
Thanksgiving staple recalled at Costco
HBA of Greater Springfield executive officer to retire
Timeshare exit company owner sentenced for tax evasion
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.